Statements (49)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:Company
|
| gptkbp:awards |
Various industry awards
|
| gptkbp:CEO |
gptkb:Patrick_Soon-Shiong
|
| gptkbp:clinicalTrials |
Ongoing
Phase 1 Phase 2 Phase 3 |
| gptkbp:collaborations |
Academic institutions
Research organizations |
| gptkbp:community_engagement |
Health education programs
Patient support initiatives |
| gptkbp:employees |
Over 100
|
| gptkbp:financials |
Private funding
Revenue growth Investment rounds |
| gptkbp:focus |
Cancer treatment
|
| gptkbp:founded |
2015
|
| gptkbp:founder |
gptkb:Patrick_Soon-Shiong
|
| gptkbp:future_plans |
Increase market presence
Enhance research capabilities Expand product pipeline Advance patient care Collaborate with leading experts |
| gptkbp:headquarters |
gptkb:Culver_City,_California
|
| https://www.w3.org/2000/01/rdf-schema#label |
NantCell, Inc.
|
| gptkbp:industry |
Biotechnology
|
| gptkbp:investmentFocus |
Various venture capital firms
|
| gptkbp:keyPeople |
gptkb:Patrick_Soon-Shiong
|
| gptkbp:location |
gptkb:United_States
|
| gptkbp:mission |
Transform cancer care
|
| gptkbp:partnerships |
Various pharmaceutical companies
|
| gptkbp:patentCitation |
Multiple patents filed
|
| gptkbp:philanthropy |
Various health initiatives
|
| gptkbp:products |
gptkb:NantCancer_Vaccine
gptkb:NantHealth NantKID |
| gptkbp:regulatoryCompliance |
EMA_approvals
FDA_approvals |
| gptkbp:research_focus |
Cell therapy
Personalized medicine Immunotherapy |
| gptkbp:subsidiary |
gptkb:NantHealth
gptkb:NantWorks NantKID |
| gptkbp:technology |
Artificial intelligence
Genomics Data analytics |
| gptkbp:type |
Private
|
| gptkbp:website |
www.nantcell.com
|